Sjögren's Disease
A Brand New
Study !
Sjogren’s syndrome is an immune system illness. It occurs when the body’s immune system attacks its own healthy cells. Sjogren’s often occurs with other immune ailments, such as rheumatoid arthritis and lupus.
The two most common symptoms are dry eyes and a dry mouth. Eyes might itch or burn. The mouth might feel full of cotton
Treatments include eye drops, medicines and eye surgery to relieve symptoms.
What is the Sjögren's Study?
The study is for participants with moderate to severe Sjogren’s to take a medicine to evaluate the effect on symptoms with the goal of relieving dryness and to reduce tender and swollen joints.
Inclusion criteria includes adults over 18 years of age with diagnosis of Sjogren’s. Must be vaccinated against Covid 19 and be negative for Tuberculosis.
Exclusion Criteria includes history of deep vein thrombosis. Polymyositis, systemic sclerosis or dermatomyositis. If you are pregnant or lactating, have a history of Hepatitis B or C, have had previous treatment with biologic B Cell depleting therapy within the last 12 months or are on antimalarials, methotrexate, azathioprine, DMARD’s, immunosuppressant or antiproliferative agents, this study may not work for you.
Potential Benefits of the Sjögren's Study
- Here are some of the benefits:
- Advances understanding and treatment of Sjögren's syndrome.
- Access to innovative therapies and interventions.
- Comprehensive medical monitoring and specialized care.
- Contribution to scientific knowledge and future advancements.
- Supportive community engagement and resources.
Bradenton Research Center:
Meeting Tomorrow’s Medical Care
The primary objective of a clinical trial is to evaluate the safety and efficacy of a new treatment or intervention in alleviating the symptoms. Researchers aim to determine whether the investigational therapy can effectively reduce the severity of episodes and enhance the overall quality of life for individuals suffering from Sjogren’s.
By conducting rigorous clinical trials, researchers can gather crucial data to support the development of more effective and evidence-based treatments, ultimately benefiting those affected by this debilitating mental health condition.
Contact us today!